Simple Summary This review explores the challenges of drug resistance in cancer treatment
and discusses innovative strategies to overcome them. Researchers aim to understand how …

Solid Lipid Nanocarriers (SLNs) offer a promising avenue for breast cancer treatment, a
disease that accounts for 12.5% of global cancer cases. Despite strides in combined …

Cancer drug resistance stands as a formidable obstacle in the relentless fight against the top
five prevalent cancers: breast, lung, colorectal, prostate, and gastric cancers. These …

Breast cancer that overexpresses Human Epidermal Growth Factor Receptor 2 (HER2+) due
to gene amplification or overexpression constitutes 15-20% of all breast cancer cases …

Background: Different molecular subtypes, including HER2-positive, have been identified in
breast cancer. The overexpression of HER2 triggers downstream signaling pathways such …

抗体药物偶联物(ADCs) 由靶向特异性抗原的单克隆抗体药物和小分子细胞毒药物通过连接子偶
联而成, 它结合了高特异性靶向能力和强效杀伤作用的优势, 实现了对癌细胞的精准高效打击 …

Breast cancer is one of the most commonly diagnosed forms of the disease, and it is also the
leading cause of cancer-related deaths among women worldwide. One of the most important …

Breast cancer is a multifaceted disease that has many subcategories characterized by
unique genetic features. This research focuses on two important subgroups, including ER+ …

While local therapeutic treatments for cancer effectively eradicate primary tumor tissue, they
are rarely successful in suppressing metastatic disease. Our previous research has …